Drug Delivery and Formulation America 2012

More information on Drug Delivery and Formulation America

Overview:

This year’s multi-streamed sessions include:

• Controlled and modified release technologies for product lifecycle extensions
• Development and optimization of protein formulations
• Preventing aggregation and ensuring stability in biologic formulation
• Out-sourcing and in-licensing
• Regulatory viewpoint on partnerships and safeguarding intellectual property
• Managing relationships in drug delivery partnerships – effective deal structures
• Applications of nanotechnology and particle size reduction in combating issues of bioavailability
• Exploring different routes of administration in enhancing macromolecule delivery

Program highlights include:

• “Applying predictive and simulation modelling in formulation and delivery” Val Harding, Vice President, Global Pharmaceutical Science, Pfizer
• “Utilizing novel formulation technologies during pre-clinical and clinical development in enhancing solubility” James Dr Pipkin, Sr. Director Product Development, CyDex Pharmaceuticals
• “Deploying a more aggressive approach to pharmaceutical development – an Exelixis Development Model” Dr Khalid Shah, Senior Director, Formulation, Exelixis

View the latest program Here >>> http://www.ddfsummit.com/program

Book your place as a delegate today for US $1995 at
http://www.ddfsummit.com/offer

Your delegate package includes:

• Access to all conference sessions including streams and workshops
• Pre-arranged meetings with leading solution providers
• Attend all networking activities
• Hosted Luncheons and drinks receptions
• On-line summit catalog with detailed information on all attendees
• Conference notes on-line for future reference and knowledge sharing

More

Registration